Our paper, “Cystatin C: A Promising Test for Insurance Screening,” was published in early 2009.
Hank George, FALU
There was an eye-opening report in the September issue of On the Risk.
by Hank George, FALU
Slides from Hank’s presentation on Super-Simplified Life at the May, 2015 LOMA/LIMRA Life Conference
Hank’s research paper on bilirubin and underwriting shows why this test matters in underwriting.
Hank George, FALU, CLU, FLMI
It is a widely held notion that one does not have to know the job to manage people who do the job.
I recently read one of those garden variety diatribes bemoaning the fact that employees do not exhibit the same degree of loyalty to their employers as their predecessors did in the “good old days.”
E-cigarette use has become a hot topic in our profession as we grapple with how to underwrite users.
Hank's 3rd NT-proBNP research paper is now available. It covers the world literature on this remarkable test from 2009 to early 2014.
Prior papers can be found here:
The prevailing mantra of senior management regarding underwriting and most other operational functions is "faster, cheaper, better."
The success of simplified life products in the marketplace will be greatly impacted by how the premium rates match up against fully underwritten products.
This paper compares and analyzes findings from the 2007 and 2011 Life Underwriting Requirement surveys.
The 2010 Pharmacy (Rx) Profile survey was completed by 99 insurers doing individual life business in the United States.
Hank's newest paper "Red Blood Cell Distribution Width (RDW): Mortality & Morbidity Implications" is now available.
by Hank George, FALU, CLU, FLMI
The risk implications of failure to take medication as prescribed are not widely-appreciated by underwriters.
By Hank George, FALU, CLU, FLMI
Slides from Hank's presentation at the Critical Issues in Medical Underwriting Seminar held May 7 at the Chicago O'Hare Sheraton Four Points Hotel.
We surveyed U.S. reinsurers regarding their practices and viewpoints
about use of the NT-proBNP cardiac test by their clients. The report of this survey will be of keen interest to insurers using (or contemplating the use of) NT-proBNP.
This paper aims to provide what underwriters and claims examiners need to know about this ever-expanding aggregation of synthetic drugs that are luring users with their enhanced Cannabis-like effects.
This guide is intended to assist health underwriters who choose to transition from health underwriting to life underwriting.
This paper covers the underwriting implications of "burning mouth syndrome."
Please enter your Insureintell.com account information below.